Hirohisa Kano

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers

Hiromi Watanabe, Eiki Ichihara, Hiroe Kayatani et al. · Cancer Science · 2021 · 55 citations · Full text

Medicine, Oncology, Pharmacology +17

Adverse pregnancy and perinatal outcome in patients with recurrent pregnancy loss: Multiple imputation analyses with propensity score adjustment applied to a large‐scale birth cohort of the Japan Environment and Children’s Study

Mayumi Sugiura‐Ogasawara, Takeshi Ebara, Yasuyuki Yamada et al. · American Journal of Reproductive Immunology · 2018 · 48 citations · Full text

Public Health, Maternal Health, Obstetrics +14

Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC)

Hiromi Watanabe, Eiki Ichihara, Hirohisa Kano et al. · Internal Medicine · 2017 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY)

Kiichiro Ninomiya, Tae Hata, Hiroshige Yoshioka et al. · CHEST Journal · 2019 · 39 citations

Medicine, Oncology, Pathology +14

Endometriosis and Recurrent Pregnancy Loss as New Risk Factors for Venous Thromboembolism during Pregnancy and Post-Partum: The JECS Birth Cohort

Mayumi Sugiura‐Ogasawara, Takeshi Ebara, Taro Matsuki et al. · Thrombosis and Haemostasis · 2019 · 32 citations · Full text

Medicine, Gynecology, Obstetrics +17